Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

3.29
Delayed Data
As of 3:59pm ET
 -0.01 / -0.30%
Today’s Change
2.65
Today|||52-Week Range
5.63
-17.96%
Year-to-Date

Today’s Trading

Previous close3.30
Today’s open3.30
Day’s range3.18 - 3.38
Volume472,205
Average volume (3 months)143,282
Market cap$139.5M
Dividend yield--
Data as of 3:59pm ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)-853.85%
Earnings growth (this year)-14.49%
Earnings growth (next 5 years)--
Revenue growth (last year)-99.90%
P/E ratioNM
Price/Sales2,402.53
Price/Book0.81

Competitors

 Today’s
change
Today’s
% change
NAVBNavidea Biopharmaceu...+0.05+5.52%
ASMBAssembly Biosciences...-0.17-2.14%
XENEXenon Pharmaceutical...+0.18+2.21%
KURAKura Oncology Inc-0.09-1.35%
Data as of 4:02pm ET, 09/28/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$70.0K
Annual profit (last year)-$41.3M
Net profit margin-58,956.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Michael A. Sherman
Director &
Chief Science Officer
Philip S. Low
Corporate headquarters
West Lafayette, Indiana

Forecasts

Search for Jobs